- 3.3Impact Factor
- 6.8CiteScore
- 14 daysTime to First Decision
Emerging Technologies and Approaches for the Prevention and Treatment of Zoonotic Diseases
This special issue belongs to the section “Vaccines and Therapeutic Developments“.
Special Issue Information
Dear Colleagues,
Zoonotic diseases continue to pose significant risks to global health, emphasizing the need for coordinated efforts across human, animal, and environmental sectors. This Special Issue invites original research and reviews on novel technologies for the prevention and treatment of zoonotic diseases, with a focus on integrated One Health strategies.
We welcome contributions on recent advances in vaccine development—mRNA, viral vector, nanoparticle-based, and thermostable platforms—as well as immunotherapeutic approaches, such as monoclonal antibodies and cytokine-based interventions. Studies addressing biotherapeutics, such as bacteriophages, endolysins, and microbiome-derived products, are also encouraged. Submissions that bridge veterinary and human medicine are particularly relevant, especially those providing insights into cross-species prevention and control of infectious diseases.
This Special Issue aims to contribute to the global scientific effort to develop effective, innovative, and sustainable solutions for zoonotic disease management.
Dr. Alejandra Capozzo
Dr. Jesús Hernández
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- one health
- zoonotic diseases
- vaccines
- immunotherapy and biotherapeutics
- cross-species disease prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

